• 1
    Deim K. Synopsis of plasma proteins. In: Scientific Tables, 6th edn. Basel: Documenta Geigy, 1962.
  • 2
    Redman CM. Biosynthesis of serum proteins and ferritin by free and attached ribosomes of rat liver. Biochem Biophys Res Commun 1968; 33: 5560.
  • 3
    Kimball SR, Horetsky RL, Jefferson LS. Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes. Am J Physiol 1995; 268: E6E14.
  • 4
    Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JMC. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998; 95: 45965.
  • 5
    Parving HH, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 64351.
  • 6
    Ramirez-Vick J, Vargas FF. Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. Am J Physiol 1993; 264: H1382H1387.
  • 7
    Qiao R, Siflinger-Birnboim A, Lum H, Tiruppathi C, Malik AB. Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol 1993; 265: C439C446.
  • 8
    Beck R, Bertolino S, Abbot SE, Aaronson PI, Smirnov SV. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res 1998; 83: 92331.
  • 9
    Zhang S, Li H, Ma L, et al. Polynitroxyl-albumin (PNA) plus tempol attenuate lung capillary leak elicited by prolonged intestinal ischemia and reperfusion. Free Radical Biol Med 2000; 29: 4250.
  • 10
    De Carvolho H, Matos JA, Bouskela E, Svensjo E. Vascular permeability increase and plasma volume loss induced by endotoxin is attenuated by hypertonic saline with or without dextran. Shock 1999; 12: 7580.
  • 11
    Oi Y, Aneman A, Svensson M, Ewert S, Dahlqvist M, Haljamae H. Hypertonic saline-dextran improves intestinal perfusion and survival in porcine endotoxin shock. Crit Care Med 2000; 28: 284350.
  • 12
    Nielsen VG, Tan S, Brix AE, Baird MS, Parks DA. Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. Crit Care Med 1997; 25: 156574.
  • 13
    Anning PB, Finney SJ, Winlove CP, Evans TW. Effects of fluid resuscitation on LPS induced changes in vascular permeability and neutrophil function in vivo. Am J Respir Crit Care Med 2001; 161: A555(Abstract).
  • 14
    Collis RE, Collins PW, Gutteridge CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994; 20: 3741.
  • 15
    Halliwell B. Albumin—an important extra cellular anti-oxidant. Biochem Pharmacol 1988; 37: 56971.
  • 16
    Rhee P, Wang D, Ruff P, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000; 28: 748.
  • 17
    Nathan C, Xie QW, Halbwachs-Mecarelli L, Jin WW. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (Sialophorin, Leukosialin). J Cell Biol 1993; 122: 24356.
  • 18
    Engel JM, Welters I, Rupp M, et al. Influence of colloid fluids on polymorphonuclear granulocyte function in vivo. Acta Anaesthesiol Scand 2001; 45: 3859.
  • 19
    King TP. On the sulfhydryl group of human plasma albumin. J Biol Chem 1961; 236: PC5.
  • 20
    Cantin AM, Paquette B, Richter M, Larivee P. Albumin mediated regulation of cellular glutathione and nuclear kappa B activation. Am J Respir Crit Care Med 2000; 162: 153946.
  • 21
    Simon DJ, Stamler JS, Jaraki O, et al. Anti-platelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium derived relaxant factor. Arteriosclerosis Thrombosis 1993; 13: 7919.
  • 22
    Marelli D, Paul A, Samson R, Edgell D, Angood P, Chiu RC. Does the addition of albumin to the prime solution in the cardiopulmonary bypass circuit affect clinical outcome? A randomized study. J Thorac Cardiovasc Surg 1989; 98: 7516.
  • 23
    Sade RM, Stroud MR, Crawford FA, Kratz JM, Dearing JP, Bartles DM. A prospective, randomised study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thoracic Cardiovasc Surg 1983; 89: 71322.
  • 24
    Moggio RA, Rha CC, Somberg ED, Praeger PI, Pooley RW, Reed GE. Haemodynamic comparison of albumin and hydroxyethyl starch in post operative cardiac surgery patients. Crit Care Med 1983; 12: 9435.
  • 25
    Treib J, Baron J-F, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Int Care Med 1999; 25: 25868.
  • 26
    Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch or Ringer's solution on thromboelastograph. Anesth Analg 2000; 90: 795800.
  • 27
    Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 76747.
  • 28
    Chalasani N, Gorski JC, Horlander JCSR, et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. Am Soc Nephrol 2001; 12: 10106.